DLT RESOLUTION, INC (DLTI) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2024-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2024-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2024-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 181.44K USD | |
| Stock-based compensation | (m) | |
| Operating income | -626.83K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | (m) | $181.44K | (m) | $-626.83K | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $177.79K | (m) | $-269.97K | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $142.74K | (m) | $-81.11K | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $157.68K | (m) | $-38.80K | $7.31K | (m) | (m) | -5.31× | Reported |
| 2023-06-30 | (m) | $185.04K | (m) | $-35.72K | $7.31K | (m) | (m) | -4.88× | Reported |
| 2023-03-31 | (m) | $209.08K | (m) | $-127.51K | $10.72K | (m) | (m) | -11.89× | Reported |
| 2022-12-31 | (m) | $218.71K | (m) | $-173.25K | $12.55K | (m) | (m) | -13.80× | Reported |
| 2022-09-30 | (m) | $339.51K | (m) | $-279.74K | $7.32K | (m) | (m) | -38.24× | Reported |
| 2022-06-30 | (m) | $337.60K | (m) | $-259.53K | $7.32K | (m) | (m) | -35.48× | Reported |
| 2022-03-31 | (m) | $356.68K | (m) | $-185.12K | $3.91K | (m) | (m) | -47.38× | Reported |
| 2021-12-31 | (m) | $391.96K | (m) | $-144.40K | $2.09K | (m) | (m) | -68.96× | Reported |
| 2021-09-30 | (m) | $1.78M | (m) | $-610.93K | $24.45K | (m) | (m) | -24.99× | Reported |
| 2021-06-30 | (m) | $2.04M | (m) | $-431.75K | $33.13K | (m) | (m) | -13.03× | Reported |
| 2021-03-31 | (m) | $2.17M | (m) | $-314.54K | $41.78K | (m) | (m) | -7.53× | Reported |
| 2020-12-31 | (m) | $2.16M | (m) | $-458.06K | $46.91K | (m) | (m) | -9.77× | Reported |
| 2020-09-30 | (m) | $1.68M | (m) | $-475.10K | $18.02K | (m) | (m) | -26.37× | Reported |
| 2020-06-30 | (m) | $1.21M | (m) | $-552.23K | $7.96K | (m) | (m) | -69.34× | Reported |
| 2020-03-31 | (m) | $769.66K | (m) | $-530.32K | $-1.70K | (m) | (m) | (m) | Reported |
| 2019-12-31 | (m) | $463.32K | (m) | $-238.09K | $-7.32K | (m) | (m) | (m) | Reported |
| 2019-09-30 | (m) | $16.00K | (m) | (m) | $-7.30K | (m) | (m) | (m) | Reported |
| 2019-06-30 | (m) | $95.36K | (m) | (m) | $-7.32K | (m) | (m) | (m) | Reported |
| 2019-03-31 | (m) | $200.96K | (m) | (m) | $-4.64K | (m) | (m) | (m) | Reported |
| 2018-12-31 | (m) | $227.34K | (m) | (m) | $-4.77K | (m) | (m) | (m) | Reported |
| 2018-09-30 | (m) | (m) | (m) | (m) | $8.07K | (m) | (m) | (m) | Reported |
| 2018-06-30 | (m) | (m) | (m) | (m) | $11.42K | (m) | (m) | (m) | Reported |
| 2018-03-31 | (m) | (m) | (m) | (m) | $17.55K | (m) | (m) | (m) | Reported |
| 2017-12-31 | (m) | $2.42K | (m) | (m) | $19.34K | (m) | (m) | (m) | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | $26.40K | (m) | (m) | (m) | Reported |
| 2017-06-30 | (m) | (m) | (m) | (m) | $29.18K | (m) | (m) | (m) | Reported |
| 2017-03-31 | (m) | (m) | (m) | (m) | $42.30K | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | (m) | (m) | (m) | $56.72K | (m) | (m) | (m) | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | $61.78K | (m) | (m) | (m) | Reported |
| 2016-06-30 | (m) | (m) | (m) | (m) | $65.16K | (m) | (m) | (m) | Reported |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $32.18K | (m) | (m) | (m) | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.